2011
DOI: 10.1002/adma.201102435
|View full text |Cite
|
Sign up to set email alerts
|

Aptamer‐Mediated Efficient Capture and Release of T Lymphocytes on Nanostructured Surfaces

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

5
155
0
1

Year Published

2012
2012
2024
2024

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 177 publications
(161 citation statements)
references
References 46 publications
5
155
0
1
Order By: Relevance
“…Although not all of the captured cells were released with the current device, the ability to release cells minimally invasively (8,15,41) represents a significant step toward studying the biology of these cells or screening for new drugs. One could envision that by encoding restriction sites for different restriction enzymes in the RCA product, one could release captured cells in a selective manner.…”
Section: Discussionmentioning
confidence: 99%
“…Although not all of the captured cells were released with the current device, the ability to release cells minimally invasively (8,15,41) represents a significant step toward studying the biology of these cells or screening for new drugs. One could envision that by encoding restriction sites for different restriction enzymes in the RCA product, one could release captured cells in a selective manner.…”
Section: Discussionmentioning
confidence: 99%
“…To realize such control, different functional substrates have been developed, where cell adhesion can be controlled in response to external stimuli, such as heat [9,10], chemicals [11], light [12][13][14], potential and enzymatic activities [15,16], etc. However, most of the stimuli-responsive substrate focuses on the single response till now, which would not satisfy the needs of double or multiple stimulation in future applications.…”
Section: Introductionmentioning
confidence: 99%
“…Compared to other small--volume biomolecule sorting systems that rely on external electric fields, 38 IR, 39 magnetic fields, 7,40 require chemical modifications of the biomolecules of interest, 41 lead to only single--time use of a given set--up, 42 or require a series of sequential steps for the release of the biomolecule and/or reuse of the device, 32, 43 our system can exploit coupled chemistries in a microfluidic channel to yield both efficient (minimal steps) and effective (recovery of almost all of the target biomolecule from solution) output.…”
Section: Discussionmentioning
confidence: 99%